Villamizar Nestor R, Darrabie Marcus D, Burfeind William R, Petersen Rebecca P, Onaitis Mark W, Toloza Eric, Harpole David H, D'Amico Thomas A
Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
J Thorac Cardiovasc Surg. 2009 Aug;138(2):419-25. doi: 10.1016/j.jtcvs.2009.04.026.
Advantages of thoracoscopic lobectomy include less postoperative pain, shorter hospitalization, and improved delivery of adjuvant chemotherapy. The incidence of postoperative complications has not been thoroughly assessed. This study analyzes morbidity after lobectomy to compare the thoracoscopic approach and thoracotomy.
By using a prospective database, the outcomes of patients who underwent lobectomy from 1999-2009 were analyzed with respect to postoperative complications. Propensity-matched groups were analyzed based on preoperative variables and stage.
Of the 1079 patients in the study, 697 underwent thoracoscopic lobectomy, and 382 underwent lobectomy by means of thoracotomy. In the overall analysis thoracoscopic lobectomy was associated with a lower incidence of atrial fibrillation (P = .01), atelectasis (P = .0001), prolonged air leak (P = .0004), transfusion (P = .0001), pneumonia (P = .001), sepsis (P = .008), renal failure (P = .003), and death (P = .003). In the propensity-matched analysis based on preoperative variables, when comparing 284 patients in each group, 196 (69%) patients who underwent thoracoscopic lobectomy had no complications versus 144 (51%) patients who underwent thoracotomy (P = .0001). In addition, thoracoscopic lobectomy was associated with a lower incidence of atrial fibrillation (13% vs 21%, P = .01), less atelectasis (5% vs 12%, P = .006), fewer prolonged air leaks (13% vs 19%, P = .05), fewer transfusions (4% vs 13%, P = .002), less pneumonia (5% vs 10%, P = .05), less renal failure (1.4% vs 5%, P = .02), shorter chest tube duration (median of 3 vs 4 days, P < .0001), and shorter length of hospital stay (median of 4 vs 5 days, P < .0001).
Thoracoscopic lobectomy is associated with a lower incidence of major complications, including atrial fibrillation, compared with lobectomy by means of thoracotomy. The underlying factors responsible for this advantage should be analyzed to improve the safety and outcomes of other thoracic procedures.
电视胸腔镜肺叶切除术的优点包括术后疼痛减轻、住院时间缩短以及辅助化疗的实施得到改善。术后并发症的发生率尚未得到全面评估。本研究分析肺叶切除术后的发病率,以比较电视胸腔镜手术和开胸手术。
通过使用前瞻性数据库,分析1999年至2009年接受肺叶切除术患者的术后并发症情况。根据术前变量和分期分析倾向匹配组。
在该研究的1079例患者中,697例行电视胸腔镜肺叶切除术,382例行开胸肺叶切除术。在总体分析中,电视胸腔镜肺叶切除术与房颤(P = 0.01)、肺不张(P = 0.0001)、持续漏气时间延长(P = 0.0004)、输血(P = 0.0001)、肺炎(P = 0.001)、脓毒症(P = 0.008)、肾衰竭(P = (0.003)及死亡(P = 0.003)的发生率较低相关。在基于术前变量的倾向匹配分析中,比较每组284例患者时,196例(69%)接受电视胸腔镜肺叶切除术的患者无并发症,而144例(51%)接受开胸手术的患者无并发症(P = 0.0001)。此外,电视胸腔镜肺叶切除术与房颤发生率较低(13% 对21%,P = 0.01)、肺不张较少(5% 对12%,P = 0.006)、持续漏气时间延长较少(13% 对19%,P = 0.05)、输血较少(4% 对13%,P = 0.002)、肺炎较少(5% 对10%,P = 0.05)、肾衰竭较少(1.4% 对5%,P = 0.02)、胸管留置时间较短(中位数为3天对4天,P < 0.0001)及住院时间较短(中位数为4天对5天,P < 0.0001)相关。
与开胸肺叶切除术相比,电视胸腔镜肺叶切除术与包括房颤在内的主要并发症发生率较低相关。应分析导致这一优势的潜在因素,以提高其他胸部手术的安全性和疗效。